A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency

A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency

In this study, we sought to evaluate the inter-batch consistency and safety of the CTN-1 V human rabies vaccine (Vero cells). A total of 594 healthy participants aged 10–60 years were enrolled from Mianzhu, Sichuan Province, and randomized into three batch groups to receive vaccination via the Essen...

Full description

Bibliographic Details
Main Authors: Lei Zhou, Jingjing Liu, Jia Li, Xuecheng Liu, Jingwu Zhang, Fei Nie, Jianmin Chen, Jing Chai, Jinchao Lv, Minghui Wang, Jiajie Yu, Wenjie Wu, Yuhua Li, Yuhui Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
human rabies vaccine
ctn-1v strain
safety
immunogenicity
inter-batch consistency
equivalency testing
Online Access:http://dx.doi.org/10.1080/21645515.2022.2138049

Internet

http://dx.doi.org/10.1080/21645515.2022.2138049

Similar Items